Free Trial
→ Real Americans Don’t Wait on Wall Street’s Next Move (From Premier Gold Co) (Ad)
NASDAQ:NPCE

NeuroPace Q1 2025 Earnings Report

NeuroPace logo
$10.79 +0.36 (+3.45%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$10.79 0.00 (0.00%)
As of 04/17/2025 05:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Earnings HistoryForecast

NeuroPace EPS Results

Actual EPS
N/A
Consensus EPS
-$0.26
Beat/Miss
N/A
One Year Ago EPS
N/A

NeuroPace Revenue Results

Actual Revenue
N/A
Expected Revenue
$21.85 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

NeuroPace Announcement Details

Quarter
Q1 2025
Date
5/14/2025
Time
Before Market Opens
Conference Call Date
Tuesday, May 13, 2025
Conference Call Time
4:30PM ET

Conference Call Resources

NeuroPace Earnings Headlines

NeuroPace, Inc.: NeuroPace Provides Update on Tariff Status
April 17 at 9:59 AM | finanznachrichten.de
NeuroPace expects minimal impact from tariffs
April 15, 2025 | markets.businessinsider.com
Real Americans Don’t Wait on Wall Street’s Next Move
What's happening in the markets right now should concern every freedom-loving American who's worked hard and saved smart. Your 401(k) doesn't deserve to be dragged through the mud by tariffs, trade wars, reckless spending, and political standoffs. And you don't have to stand by while Wall Street plays roulette with your future.
April 19, 2025 | Premier Gold Co (Ad)
NeuroPace Provides Update on Tariff Status
April 14, 2025 | globenewswire.com
NeuroPace, Inc.: NeuroPace Announces Data From a Long-Term Post-Approval Study of the RNS System in Focal Epilepsy at the 2025 AAN Annual Meeting
April 8, 2025 | finanznachrichten.de
NeuroPace announces data from long-term post-approval study of RNS System
April 8, 2025 | markets.businessinsider.com
See More NeuroPace Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like NeuroPace? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NeuroPace and other key companies, straight to your email.

About NeuroPace

NeuroPace (NASDAQ:NPCE) operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

View NeuroPace Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles